Stuttgart - Delayed Quote • EUR
Celldex Therapeutics Inc (TCE2.SG)
As of 8:01 AM GMT+2. Market Open.
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is S&P 500
Return | TCE2.SG | S&P 500 |
---|---|---|
YTD | +0.56% | +5.05% |
1-Year | +10.43% | +21.22% |
3-Year | +63.04% | +21.18% |